share_log

Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 14 05:51
Summary by Futu AI
Merck & Co. Inc. officer Robert M. Davis is set to sell 150,000 shares of the company's common stock, with an aggregate market value of approximately $18,872,130, on February 13, 2024. The shares to be sold were acquired through the exercise of options under a registered plan, with two significant acquisitions on May 1, 2020, and May 4, 2021, totaling 41,509 and 108,491 shares respectively. The transactions were part of a structured plan for acquiring securities directly from the issuer. There have been no sales of securities reported in the past three months prior to this notice.
Merck & Co. Inc. officer Robert M. Davis is set to sell 150,000 shares of the company's common stock, with an aggregate market value of approximately $18,872,130, on February 13, 2024. The shares to be sold were acquired through the exercise of options under a registered plan, with two significant acquisitions on May 1, 2020, and May 4, 2021, totaling 41,509 and 108,491 shares respectively. The transactions were part of a structured plan for acquiring securities directly from the issuer. There have been no sales of securities reported in the past three months prior to this notice.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.